Published in
Wiley Open Access, Cancer Medicine, 14(8), p. 6195-6211, 2019
DOI: 10.1002/cam4.2399
Links
Tools
Efficacy, immunogenicity and safety of the AS04‐HPV‐16/18 vaccine in Chinese women aged 18‐25 years: End‐of‐study results from a phase II/III, randomised, controlled trial
Journal article published in 2019 by
Feng‐Cai Zhu,
Shang‐Ying Hu,
Ying Hong,
Yue‐Mei Hu,
Xun Zhang,
Yi‐Ju Zhang,
Qin‐Jing Pan,
Wen‐Hua Zhang,
Fang‐Hui Zhao 
,
Cheng‐Fu Zhang,
Xiaoping Yang,
Jia‐Xi Yu,
Jiahong Zhu,
Yejiang Zhu,
Feng Chen
and other authors.
,
Cheng‐Fu Zhang,
Xiaoping Yang,
Jia‐Xi Yu,
Jiahong Zhu,
Yejiang Zhu,
Feng Chen
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 